Single-photon emission computed tomography gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 14, Issue 9, 1996, Pages 2473-2479

  Vose, J M ^a   Bierman, P J ^a   Andersen, J R ^a   Harrison, K A ^a   Dalrymple, G V ^a   Byar, K ^a   Kessinger, A ^a   Armitage, J O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GALLIUM; HYDROXYUREA;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

EID: 0029781861     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.9.2473     Document Type: Article

References (24)

1. Canellos GP: Residual mass in lymphoma may not be residual disease. J Clin Oncol 6:931-933, 1988
2. Surbone A, Longo DL, DeVita VT, et al: Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: Significance and management. J Clin Oncol 6:1832-1837, 1988
3. Jochelson MS, Herman TG, Stomper PC, et al: Planning mantle radiation therapy in patients with Hodgkin's disease: The role of gallium-67 scintigraphy. AJR Am J Roentgenol 151:1229-1232, 1988
4. Henkin PE, Polcyn PE, Quinn JL III: Scanning treated Hodgkin's disease with Ga-67 citrate. Radiology 110:151-154, 1974
5. Kaplan WD, Jochelson MS, Herman TS, et al: Gallium-67 imaging: A predictor of residual tumor viability and clinical outcome of patients with diffuse large-cell lymphoma. J Clin Oncol 8:1966-1970, 1990
6. Anderson KC, Leonard RCF, Canellos GP, et al: High-dose gallium imaging in lymphoma. Am J Med 75:327-331, 1983
7. Kaplan GL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
8. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: Analysis and examples. Br J Cancer 35:1-39, 1977
9. Lewis E, Bernardino ME, Salvador PG, et al: Post therapy CT-detected mass in lymphoma patients: Is it viable tissue? J Comput Assist Tomagr 6:792-795, 1982
10. Stewart FM, Williamson BR, Innes DJ, et al: Residual tumor masses following treatment for advanced histiocytic lymphoma. Diagnostic and therapeutic implications. Cancer 55:620-623, 1985
11. 3H] deoxyglucose in the tumor model following chemotherapy and radiotherapy. J Nucl Med 26:278-282, 1985
12. Gunasekeva SW, King LJ, Lavender PJ: The behavior of tracer gallium-67 towards serum proteins. Clin Chim Acta 39:401-406, 1972
13. Anghileri LJ: Cell membrane permeability and tumor scanning agents: Facts and possibilities. J Nucl Med Allied Sci 22:101-103, 1978
14. Muranaka A, Ito Y, Hashimoto M, et al: Uptake and excretion of 67-Ga-citrate in malignant tumors and normal cells. Eur J Nucl Med 5:31-37, 1980
15. Front D, Israel O, Epelbaum R, et al: Ga-67 SPECT before and after treatment of lymphoma. Radiology 175:515-519, 1990
16. Front D, Ben-Haim S, Israel O, et al: Lymphoma: Predictive value of Ga-67 scintigraphy after treatment. Radiology 182:359-363, 1992
17. Janicek M, Kaplan W, Neuberg D, et al: Early restaging gallium scans identifying durable response to induction therapy in high risk patients with aggressive non-Hodgkin's lymphoma (NHL). Blood 84:916a, 1994 (abstr)
18. Kaplan WD: Gallium tumor imaging. Postgrad Radiol 4:145-173, 1984
19. Brachman MB, Ramanna L, Tanasescu DE, et al: Gallium tumor scanning: How many days between injection and imaging? J Nucl Med 27:1038-1031, 1986
20. Even-Sapir E, Bar-Shalom R, Israel O, et al: Single-photon emission computed tomography quantitation of gallium citrate uptake for the differentiation of lymphoma from benign hilar uptake. J Clin Oncol 13:942-946, 1995
21. Abrahamsen AF, Lien HH, Aas M, et al: Magnetic resonance imaging and 67-gallium scan in mediastinal malignant lymphoma: A prospective pilot study. Ann Oncol 5:433-436, 1994
22. Paul R: Comparison of fluorine 18-2-fluorodeoxyglucose and gallium-67 citrate for detection of lymphoma. J Nucl Med 28:288-292, 1987
23. van den Anker-Lugtenburg PJ, Krenning EP, Oel HY, et al: The role of somatostatin receptor scintigraphy in the initial staging of Hodgkin and non-Hodgkin lymphomas. Blood 84:917a. 1994 (abstr)
24. 111In-octreotide in the staging of lymphoma. A comparison to other imaging modalities. Blood 84:918a, 1994 (abstr)